Tesla’s intellectual gamble
By Guy Dorrell @GuyDorrellEsq Pfizer’s abortive bid to take control of Astra Zenica in May 2014 was widely commented to have been motivated, at least in part, by Research and Development issues. More specifically, Pfizer has for some time relied upon the cash-cows of its existing products; bolstering its share ...